Come join WCG at the DIA 2019 Global Annual Meeting in San Diego. The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe.

As the largest, longest-running event in the life sciences industry, this gathering is designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. The DIA 2019 Global Annual Meeting will host thousands of professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe and 400+ exhibiting companies.

Connect with WCG at the conference

  • To schedule a meeting with a WCG representative during the event, please complete the form.
  • Visit us at Booth #1005 and #1105
  • Please see below for a list of WCG’s speaking sessions at the event.

WCG Speaking Sessions at DIA 2019 Global Meeting

June 24

When Disaster Strikes: Developing a Proactive Plan to Address Challenges Brought on by Large Scale Natural Disasters
11:00 AM
Room 10 in the San Diego Convention Center
Speaker: Mark Summers
President, Patient Engagement, WCG
Co-Presenter:
• Jennifer Sheller, Regional Head, NA, Global Clinical Trial Operations at Merck & Co., Inc.

Getting the Most Out of Your Site Selection Strategy
1:00 PM
Theater 2 Exhibit Hall in the San Diego Convention Center
Speaker: Suzanne Caruso
Vice President, Clinical Solutions, WCG

Opportunities and Challenges with First-In-Human Multiple Expansion Cohort Designs in Oncology
2:15 PM
Room 2 in the San Diego Convention Center
Speaker: Lindsay McNair
Chief Medical Officer, WCG
Co-Presenters:
• Pamela Balcazar, Regulatory Health Project Manager, OHOP, CDER, FDA
• Sherry Leonard, Director, Regulatory Affairs at Celgene Corporation

June 25

Pharmacovigilance Reporting and Quality
8:00 AM
Room 17AB in the San Diego Convention Center
Speaker: Steven Beales
Senior Vice President, Information Technology & Market Owner, Safety Solutions, WCG
Co-Presenters:
• Andrea Best, Executive Medical Director at Abbvie, Inc.
• David Fryrear, Senior Director, R&D Quality Assurance at Abbvie, Inc.
• Kelly Traverso, Consulting Specialist Leader at Deloitte
• Stacey Basham, Director, Clinical QA at Abbvie, Inc.

Conducting Clinical Trials with GMOs: Strategies to Overcome Regulatory, Operational, and Patient Enrollment Challenges
8:00 AM
Room 6E in San Diego Convention Center
Speaker: Daniel Kavanagh
Senior Scientific Advisor, Gene Therapy WCG
Co-Presenters:
• Esther Mahillo, Customer Relationships Executive, Oncology and Hematology, Syneos Health
• Kathleen Higgins, Director of Community Outreach, Li Fraumeni Syndrome Association

Retooling Risk Assessment to Align with ICH-E6(R2) and Connect to Centralized Monitoring and Risk-Based Monitoring
10:30 AM
Room 11A in San Diego Convention Center
Speaker: Linda Sullivan
Metrics Champion Consortium Co-Founder & Executive Director, WCG
Co-Presenters:
• Suzanne Lukac, Senior Account Director at CluePoints
• Ann McCabe, Director, Process Excellence & Risk Management at Daiichi Sankyo, Inc.
• Sherry Merrifield, Senior Director, Global Operations Management at Syneos Health

Outcomes, Endpoints, and Methods Supporting Oncology and Alzheimer’s Therapies
10:30 AM
Room 9 in the San Diego Convention Center
Speaker: Christopher Randolph
Chief Scientific Officer, WCG MedAvante-ProPhase
Co-Presenters:
• Imad Al-Dakkak, Director at Huron Consulting Group
• Brad Sanderson, Senior Scientific Advisor at CRF Bracket

June 26

Returning Plain Language Summaries to Research Participants: Best Practices and the Role of the IRB
2:00 PM
Room 4 in the San Diego Convention Center
Speaker: Lindsay McNair
Chief Medical Officer, WCG
Co-Presenters:
• Kenneth Getz, Director of Sponsored Research Programs and Associate Professor, Center for the Study of Drug Development at Tufts University School of Medicine
• Jill McNair, Senior Director, Patient Engagement at CISCRP